Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Non-alcoholic Fatty Liver Disease/complications"'
Autor:
Juraj Krznarić, Maja Mijić, Ivana Štromar Knežević, Dora Šuk, Tajana Filipec Kanižaj, Adriana Vince, Neven Papić
Publikováno v:
Liječnički vjesnik, Vol 143, Iss 5-6, Pp 220-226 (2021)
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease associated with systemic changes in immune response that drives the progression to non-alcoholic steatohepatitis (NASH), liver cirrhosis, and hepatocellular carcinoma
Externí odkaz:
https://doaj.org/article/9ab9fede09554aba9707d77e67eb21b0
Autor:
Vineesh Indira Chandran, Charlotte Wilhelmina Wernberg, Mette Munk Lauridsen, Maria Kløjgaard Skytthe, Sofie Marchsteiner Bendixen, Frederik Tibert Larsen, Camilla Dalby Hansen, Lea Ladegaard Grønkjær, Majken Storm Siersbæk, Tina Di Caterino, Sönke Detlefsen, Holger Jon Møller, Lars Grøntved, Kim Ravnskjaer, Søren Kragh Moestrup, Maja Sofie Thiele, Aleksander Krag, Jonas Heilskov Graversen
Publikováno v:
Indira Chandran, V, Wernberg, C W, Lauridsen, M M, Skytthe, M K, Bendixen, S M, Larsen, F T, Hansen, C D, Grønkjær, L L, Siersbæk, M S, Caterino, T D, Detlefsen, S, Møller, H J, Grøntved, L, Ravnskjaer, K, Moestrup, S K, Thiele, M S, Krag, A & Graversen, J H 2023, ' Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness ', Hepatology, vol. 77, no. 2, pp. 558-572 . https://doi.org/10.1002/hep.32620
Background and Aims: Reliable noninvasive biomarkers are an unmet clinical need for the diagnosis of NASH. This study investigates the diagnostic accuracy of the circulating triggering receptor expressed on myeloid cells 2 (plasma TREM2) as a biomark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36081c0eb744ea8f1e710116091680a8
https://doi.org/10.1002/hep.32620
https://doi.org/10.1002/hep.32620
Publikováno v:
Frontiers in Endocrinology, 13:1057261. Frontiers Media S.A.
IntroductionMetabolic dysfunction-associated fatty liver disease (MAFLD) is known to be the most common chronic liver disease worldwide, and accumulating evidence suggests that skeletal muscle might play an important role in metabolic health. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b43050516ac66f6326cfc262a2e41c2
https://pubmed.ncbi.nlm.nih.gov/36531457
https://pubmed.ncbi.nlm.nih.gov/36531457
Autor:
Karolina Drożdż, Katarzyna Nabrdalik, Hanna Kwiendacz, Mirela Hendel, Anna Olejarz, Andrzej Tomasik, Wojciech Bartman, Jakub Nalepa, Janusz Gumprecht, Gregory Y. H. Lip
Publikováno v:
Drożdż, K, Nabrdalik, K, Kwiendacz, H, Hendel, M, Olejarz, A, Tomasik, A, Bartman, W, Nalepa, J, Gumprecht, J & Lip, G Y H 2022, ' Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease : a machine learning approach ', Cardiovascular Diabetology, vol. 21, no. 1, 240 . https://doi.org/10.1186/s12933-022-01672-9
Background Nonalcoholic fatty liver disease is associated with an increased cardiovascular disease (CVD) risk, although the exact mechanism(s) are less clear. Moreover, the relationship between newly redefined metabolic-associated fatty liver disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03ae2e5892970b97595eb4bd9e899cd4
https://pubmed.ncbi.nlm.nih.gov/36371249
https://pubmed.ncbi.nlm.nih.gov/36371249
Autor:
Ivana Štromar Knežević, Dora Šuk, Maja Mijić, Juraj Krznarić, Tajana Filipec Kanižaj, Adriana Vince, Neven Papić
Publikováno v:
Liječnički vjesnik, Vol 143, Iss 5-6, Pp 220-226 (2021)
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease associated with systemic changes in immune response that drives the progression to non-alcoholic steatohepatitis (NASH), liver cirrhosis, and hepatocellular carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edcf36ad5d5c2fa4a5ea8bf61b0db2c3
https://doi.org/10.26800/lv-143-5-6-9
https://doi.org/10.26800/lv-143-5-6-9
Autor:
Krznarić, Juraj, Mijić, Maja, Štromar Knežević, Ivana, Šuk, Dora, Filipec Kanižaj, Tajana, Vince, Adriana, Papić, Neven
Publikováno v:
Liječnički vjesnik
Volume 143
Issue 5-6
Volume 143
Issue 5-6
Nealkoholna masna bolest jetre (engl. non-alcoholic fatty liver disease, NAFLD) najčešća je kronična bolest jetre, a povezana je sa sustavnim promjenama imunosnog odgovora koje potiču progresiju u nealkoholni steatohepatitis (NASH), cirozu jetre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::72458466580a7169f0583fe0e2c73e36
https://hrcak.srce.hr/260478
https://hrcak.srce.hr/260478
Publikováno v:
PLoS ONE
PloS one, vol. 12, no. 10, pp. e0186715
PloS one, 12 (10
PloS one, Vol. 12, no. 10, p. e0186715 [1-16] (2017)
PLoS ONE, Vol 12, Iss 10, p e0186715 (2017)
PloS one, vol. 12, no. 10, pp. e0186715
PloS one, 12 (10
PloS one, Vol. 12, no. 10, p. e0186715 [1-16] (2017)
PLoS ONE, Vol 12, Iss 10, p e0186715 (2017)
Background: Cirrhosis is a heterogeneous clinical condition that includes patients at wide-ranging stages of severity. The role of the underlying liver disease on patient prognosis remains unclear. Aim: To assess the impact of the underlying liver di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae66bd5a7c2ac460a9f6a626e6924058
https://pubmed.ncbi.nlm.nih.gov/29077714
https://pubmed.ncbi.nlm.nih.gov/29077714
Simple predictors are needed for the screening of nonalcoholic fatty liver disease (NAFLD) in obese children. We aimed to assess the role of anthropometric parameters in the prediction of NAFLD. Three hundred and thirty two obese children (152 male,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::da7db9aa755e36fcd01b692f4d329f1d
Publikováno v:
University of Southern Denmark
Søholm, J, Thiele, M S & Christensen, P B 2018, ' Controlled attenuation parameter er en ny metode til screening for ikkealkoholisk fedtleversygdom ', Ugeskrift for Laeger, bind 180, nr. 17, V05170414, s. 2-5 . < http://ugeskriftet.dk/videnskab/controlled-attenuation-parameter-er-en-ny-metode-til-screening-ikkealkoholisk >
Søholm, J, Thiele, M S & Christensen, P B 2018, ' Controlled attenuation parameter er en ny metode til screening for ikkealkoholisk fedtleversygdom ', Ugeskrift for Laeger, bind 180, nr. 17, V05170414, s. 2-5 . < http://ugeskriftet.dk/videnskab/controlled-attenuation-parameter-er-en-ny-metode-til-screening-ikkealkoholisk >
Non-alcoholic fatty liver disease afflicts 30% of the population and is tightly linked to the metabolic syndrome and development of cardiovascular disease and chronic liver disease. Regular ultrasound is currently used in liver steatosis diagnosing,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::50af0dbf7a739f2defcf5bff83b1cf0a
https://portal.findresearcher.sdu.dk/en/publications/a5f2332d-c844-4ca2-85ba-663c4dcb443a
https://portal.findresearcher.sdu.dk/en/publications/a5f2332d-c844-4ca2-85ba-663c4dcb443a